| Openings between defective endothelial cells explain tumor vessel leakiness H Hashizume, P Baluk, S Morikawa, JW McLean, G Thurston, S Roberge, ... The American journal of pathology 156 (4), 1363-1380, 2000 | 2117 | 2000 |
| Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 G Thurston, C Suri, K Smith, J McClain, TN Sato, GD Yancopoulos, ... Science 286 (5449), 2511-2514, 1999 | 1759 | 1999 |
| Angiopoietin-1 protects the adult vasculature against plasma leakage G Thurston, JS Rudge, E Ioffe, H Zhou, L Ross, SD Croll, N Glazer, ... Nature medicine 6 (4), 460-463, 2000 | 1664 | 2000 |
| Imaging of angiogenesis: from microscope to clinic DM McDonald, PL Choyke Nature medicine 9 (6), 713-725, 2003 | 1378 | 2003 |
| Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors S Morikawa, P Baluk, T Kaidoh, A Haskell, RK Jain, DM McDonald The American journal of pathology 160 (3), 985-1000, 2002 | 1269 | 2002 |
| Mechanisms of adverse effects of anti-VEGF therapy for cancer T Kamba, DM McDonald British journal of cancer 96 (12), 1788-1795, 2007 | 1192 | 2007 |
| Functionally specialized junctions between endothelial cells of lymphatic vessels P Baluk, J Fuxe, H Hashizume, T Romano, E Lashnits, S Butz, ... The Journal of experimental medicine 204 (10), 2349-2362, 2007 | 1142 | 2007 |
| Increased vascularization in mice overexpressing angiopoietin-1 C Suri, J McClain, G Thurston, DM McDonald, H Zhou, EH Oldmixon, ... Science 282 (5388), 468-471, 1998 | 1076 | 1998 |
| Cellular abnormalities of blood vessels as targets in cancer P Baluk, H Hashizume, DM McDonald Current opinion in genetics & development 15 (1), 102-111, 2005 | 1049 | 2005 |
| Rapid vascular regrowth in tumors after reversal of VEGF inhibition MR Mancuso, R Davis, SM Norberg, S O’Brien, B Sennino, T Nakahara, ... The Journal of clinical investigation 116 (10), 2610-2621, 2006 | 1013 | 2006 |
| Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood YS Chang, E di Tomaso, DM McDonald, R Jones, RK Jain, LL Munn Proceedings of the National Academy of Sciences 97 (26), 14608-14613, 2000 | 962 | 2000 |
| Signalling via vascular endothelial growth factor receptor‐3 is sufficient for lymphangiogenesis in transgenic mice T Veikkola, L Jussila, T Makinen, T Karpanen, M Jeltsch, TV Petrova, ... The EMBO journal, 2001 | 937 | 2001 |
| VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature T Kamba, BYY Tam, H Hashizume, A Haskell, B Sennino, MR Mancuso, ... American Journal of Physiology-Heart and Circulatory Physiology 290 (2 …, 2006 | 913 | 2006 |
| Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement … T Inai, M Mancuso, H Hashizume, F Baffert, A Haskell, P Baluk, ... The American journal of pathology 165 (1), 35-52, 2004 | 902 | 2004 |
| Vascular endothelial–cadherin is an important determinant of microvascular integrity in vivo M Corada, M Mariotti, G Thurston, K Smith, R Kunkel, M Brockhaus, ... Proceedings of the National Academy of Sciences 96 (17), 9815-9820, 1999 | 893 | 1999 |
| Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung CG Lee, H Link, P Baluk, RJ Homer, S Chapoval, V Bhandari, MJ Kang, ... Nature medicine 10 (10), 1095-1103, 2004 | 720 | 2004 |
| Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation P Baluk, T Tammela, E Ator, N Lyubynska, MG Achen, DJ Hicklin, ... The Journal of clinical investigation 115 (2), 247-257, 2005 | 719 | 2005 |
| Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors P Baluk, S Morikawa, A Haskell, M Mancuso, DM McDonald The American journal of pathology 163 (5), 1801-1815, 2003 | 680 | 2003 |
| Significance of blood vessel leakiness in cancer DM McDonald, P Baluk Cancer research 62 (18), 5381-5385, 2002 | 651 | 2002 |
| Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis CR Ozawa, A Banfi, NL Glazer, G Thurston, ML Springer, PE Kraft, ... The Journal of clinical investigation 113 (4), 516-527, 2004 | 641 | 2004 |